Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 25, 2019Journal of Clinical OncologyOpen Access

Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

Sagar Lonial
Sagar LonialNorthwestern UniversitySJSusanna JacobusHarvard UniversityRFRafaël FonsecaUniversity of Arkansas at Little Rock

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lonial et al. (2019) studied this question.

synapsesocial.com/papers/69dd61830644c7b49d40d474https://doi.org/10.1200/jco.19.01740
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma2013 · 1,174 citations
  2. 2Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma2007 · 934 citations
  3. 3Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study2013 · 99 citations